• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers find clues to treating psychoses in mental health patients

Bioengineer by Bioengineer
May 16, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: John Kerns

Psychotic disorders often are severe and involve extreme symptoms such as delusions or hallucinations in which people lose their sense of reality. Researchers at the University of Missouri recently found evidence that boosting how well people at risk for psychosis learn from positive and negative feedback could potentially keep psychosis at bay. The team also found that brain scans using functional magnetic resonance imaging, coupled with behavioral measures, could provide markers for the diagnosis of psychosis risk. Researchers hope findings will help mental health professionals to understand how to better treat their patients with psychoses and prevent the onset of psychosis.

"Around the time Nobel Prize winner John Nash first developed psychosis he turned down an endowed chair at the University of Chicago because he said he believed he was going to become the emperor of Antarctica– despite the population of Antarctica being zero," said John G. Kerns, professor of psychological sciences in the MU College of Arts and Science. "How a genius like John Nash could develop a delusion has long baffled clinicians and scientists. We wanted to examine whether dysfunction in a brain region called the striatum and a disruption in feedback-based learning were related to risk for psychosis."

Feedback-based learning helps learners raise their awareness of strengths and weaknesses and identify actions to be taken to improve. It is heavily dependent on varying levels of dopamine, a neurotransmitter that sends signals to other nerve cells, specifically located in a specialized part of the brain called the striatum. Dopamine in the striatum provides an important teaching signal that increases or decreases the chance that certain thoughts and actions occur again in the future.

In research conducted at the Mizzou Brain Imaging Center and using a feedback-based learning task, Kerns and his team found that people at risk for psychosis are impaired when they need to rely on feedback to learn. Using fMRI brain scans, the team found that people at risk for psychosis failed to activate the striatum when they received feedback.

"Current research suggests that people like John Nash develop delusions in part because they have problems learning from feedback, like a car driving without a brake," Kerns said. "Our research is also consistent with other research that people with psychosis have an increased level of dopamine in the striatum. However, for the first time we have linked psychosis risk to both a behavioral impairment, poor feedback learning, as well as striatum dysfunction."

It is also hoped that this research will be useful in detecting risk for psychosis, Kerns said. Measuring dopamine in the striatum is both invasive and expensive and cannot be done in routine clinical assessment. However, Kerns found that non-invasive measures can be used in every day clinical practice to effectively detect striatal dysfunction. Ultimately, Kerns believes this research will help professionals both detect risk and prevent psychosis, which could mean decreased suffering for many people and their families.

###

The study, "Probabilistic Category Learning and Striatal Functional Activation in Psychosis Risk," was published in the Schizophrenia Bulletin. Funding was supported by the National Institute of Mental Health (Grants: MH014677 and MH100359) and University of Missouri research funds. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.

Media Contact

Jeff Sossamon
[email protected]
573-882-3346
@mizzounews

http://www.missouri.edu

Original Source

https://munews.missouri.edu/news-releases/2018/0516-mu-researchers-find-clues-to-treating-psychoses-in-mental-health-patients/ http://dx.doi.org/10.1093/schbul/sby033

Share13Tweet8Share2ShareShareShare2

Related Posts

COMET-T Study: Glargine 300 U/ml in Type 1 Diabetes

August 26, 2025

Ficus Lyrata Bark: A Remedy for Fatty Liver

August 26, 2025

Predicting Therapy Outcomes for EGFR-Mutated NSCLC Patients

August 26, 2025

Revolutionizing Nepal’s Health: Past Challenges and Innovations

August 26, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

COMET-T Study: Glargine 300 U/ml in Type 1 Diabetes

Ficus Lyrata Bark: A Remedy for Fatty Liver

Predicting Therapy Outcomes for EGFR-Mutated NSCLC Patients

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.